{"id":31039,"date":"2026-03-02T19:28:31","date_gmt":"2026-03-02T19:28:31","guid":{"rendered":"https:\/\/www.europesays.com\/dk\/31039\/"},"modified":"2026-03-02T19:28:31","modified_gmt":"2026-03-02T19:28:31","slug":"novo-nordisk-to-invest-506-million-in-ireland-plant-expansion-2","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/dk\/31039\/","title":{"rendered":"Novo Nordisk to invest $506 million in Ireland plant expansion"},"content":{"rendered":"<p class=\"mb-4 text-lg md:leading-8 break-words\">COPENHAGEN, March 2 (Reuters) &#8211; Novo Nordisk said on Monday \u200cit will invest 432 million \u200ceuros ($506.43 million) to expand its manufacturing \u200bfacility in Athlone, Ireland.<\/p>\n<p class=\"mb-4 text-lg md:leading-8 break-words\">\u201cWith the investment in the Athlone facility, Novo Nordisk is expanding \u200cits production \u2060capacities for oral products, which will strengthen our \u2060ability to meet both current and future demand, outside the \u200bU.S.,\u201d said \u200bNovo \u200bNordisk&#8217;s head of \u200cproduct supply, Kasper Bodker Mejlvang, in a statement.<\/p>\n<p class=\"mb-4 text-lg md:leading-8 break-words\">The investment would improve Novo Nordisk&#8217;s capacity to manufacture oral versions of its \u200cGLP-1 drugs, which \u200binclude Wegovy and \u200bOzempic, \u200bthe company added.<\/p>\n<p class=\"mb-4 text-lg md:leading-8 break-words\">The construction \u200cprojects, which have \u200balready begun, \u200bwill be finalised gradually from the end of 2027 \u200bthrough \u200c2028, Novo said.<\/p>\n<p class=\"mb-4 text-lg md:leading-8 break-words\">($1 = 0.8530 euros)<\/p>\n<p class=\"mb-4 text-lg md:leading-8 break-words\">(Reporting \u200bby Stine Jacobsen, editing \u200bby Louise Rasmussen)<\/p>\n","protected":false},"excerpt":{"rendered":"COPENHAGEN, March 2 (Reuters) &#8211; Novo Nordisk said on Monday \u200cit will invest 432 million \u200ceuros ($506.43 million)&hellip;\n","protected":false},"author":2,"featured_media":31040,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[271],"tags":[18587,3041,18588,272,18589],"class_list":["post-31039","post","type-post","status-publish","format-standard","has-post-thumbnail","category-novo-nordisk","tag-athlone","tag-ireland","tag-kasper-bodker-mejlvang","tag-novo-nordisk","tag-oral-products"],"share_on_mastodon":{"url":"","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/posts\/31039","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/comments?post=31039"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/posts\/31039\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/media\/31040"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/media?parent=31039"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/categories?post=31039"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/tags?post=31039"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}